Insider · CIK 0001258704
Robert Baumgartner V
director
Files at TECH (BIO-TECHNE Corp). First filing Aug 27, 2025, latest Aug 27, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $958k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TECH: BIO-TECHNE Corp
TECHOct 9, 2026 · close 72.46
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | BIO-TECHNE Corp | $958k 17,040 shares | -28% | +22% from low-29% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | TECH BIO-TECHNE Corp | MOption exercise Common Stock | +15,940 | $0.00 | $0 | 62,443 | 18 d ago |
| Sep 22, 2026 | TECH BIO-TECHNE Corp | FTax withholding Common Stock | -5,559 | $72.55 | $403k | 56,884 | 18 d ago |
| Sep 22, 2026 | TECH BIO-TECHNE Corp | MOption exercise Stock Options (Right to Buy)derivative | -15,940 | $0.00 | $0 | 0 | 18 d ago |
| Aug 25, 2025 | TECH BIO-TECHNE Corp | MOption exercise Common Stock | +17,040 | $21.84 | $372k | 61,903 | Aug 27, 2025 |
| Aug 25, 2025 | TECH BIO-TECHNE Corp | SOpen-market sale Common Stock | -17,040 | $56.21 | $958k | 44,863 | Aug 27, 2025 |
| Aug 25, 2025 | TECH BIO-TECHNE Corp | MOption exercise Stock Options (Right to Buy)derivative | -17,040 | $0.00 | $0 | 0 | Aug 27, 2025 |
| Oct 24, 2024 | TECH BIO-TECHNE Corp | AGrant or award Common Stock | +1,462 | $0.00 | $0 | 44,863 | Oct 28, 2024 |
| Oct 24, 2024 | TECH BIO-TECHNE Corp | AGrant or award Stock Options (Right to Buy)derivative | +3,511 | $0.00 | $0 | 3,511 | Oct 28, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.